AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Home iRADIOLOGY Article
PDF (2.3 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Fundamental Research Into and Clinical Translation of Tumor Irreversible Electroporation‐Based Ablation Therapy Devices

Haoyu Liu1Wenyuan Ma1Fan Xu1Lei Xu2Chengyue Zhang1Wenjing Lou1Liting Xie1( )Tianan Jiang1 ( )
Department of Ultrasound, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Department of Ultrasound Medicine, Affiliated Jinhua Hospital Zhejiang University School of Medicine, Jinhua, China

Haoyu Liu and Wenyuan Ma contributed equally to this work.

Show Author Information

Abstract

Irreversible electroporation (IRE) is an emerging tumor ablation technique that induces permanent damage to cellular membranes through the application of high‐intensity short‐duration electrical pulses. This process results in the formation of nanoscale pores within the cell membrane, and when the electric field exceeds a critical threshold, these pores become permanent, leading to the disruption of cellular homeostasis and ultimately initiating programmed cell death. The ability of IRE to selectively target tumor cells while preserving the adjacent neural and vascular structures makes it a promising approach to the treatment of solid tumors, including those of the liver, pancreas, and prostate. In this review, we provide a comprehensive overview of the foundational research and clinical translation of IRE‐based tumor ablation technologies, with a particular focus on electrode optimization. In addition, we explore the potential for the use of IRE in combination with immunotherapy or other emerging treatment modalities. It is anticipated that the integration of technological advancements in IRE devices with personalized treatment strategies will enhance the precision and efficacy of tumor ablation.

Graphical Abstract

References

【1】
【1】
 
 
iRADIOLOGY
Pages 98-112

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Liu H, Ma W, Xu F, et al. Fundamental Research Into and Clinical Translation of Tumor Irreversible Electroporation‐Based Ablation Therapy Devices. iRADIOLOGY, 2026, 4(2): 98-112. https://doi.org/10.1002/ird3.70068

438

Views

42

Downloads

0

Crossref

0

Web of Science

0

Scopus

Received: 30 August 2025
Revised: 28 February 2026
Accepted: 03 March 2026
Published: 14 April 2026
© 2026 The Author(s). Tsinghua University Press.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.